TrialProceedings of the National Academy of Sciences of the United States of America2015

Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer.

Rebecca S Heist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.